Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDK9 Antikörper (AA 231-372)

CDK9 Reaktivität: Human WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN2172831
  • Target Alle CDK9 Antikörper anzeigen
    CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
    Bindungsspezifität
    • 25
    • 14
    • 10
    • 10
    • 7
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 231-372
    Reaktivität
    • 96
    • 46
    • 20
    • 7
    • 5
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    Human
    Wirt
    • 92
    • 4
    • 2
    Kaninchen
    Klonalität
    • 86
    • 12
    Polyklonal
    Konjugat
    • 39
    • 6
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser CDK9 Antikörper ist unkonjugiert
    Applikation
    • 74
    • 31
    • 25
    • 25
    • 15
    • 13
    • 10
    • 8
    • 8
    • 6
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
    Kreuzreaktivität
    Human
    Homologie
    Mouse,Rat,Dog,Cow,Horse,Chicken,Rabbit
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human CDK9
    Isotyp
    IgG
    Top Product
    Discover our top product CDK9 Primärantikörper
  • Applikationshinweise
    WB 1:300-5000
    ELISA 1:500-1000
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
    Haltbarkeit
    12 months
  • Target
    CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
    Andere Bezeichnung
    CDK9 (CDK9 Produkte)
    Synonyme
    C-2k antikoerper, CDC2L4 antikoerper, CTK1 antikoerper, PITALRE antikoerper, TAK antikoerper, wu:fb22e09 antikoerper, wu:fc06c02 antikoerper, c-2k antikoerper, cdc2l4 antikoerper, cdk9 antikoerper, ctk1 antikoerper, pitalre antikoerper, tak antikoerper, CDK9 antikoerper, CG5179 antikoerper, Dmel\\CG5179 antikoerper, P-TEF antikoerper, P-TEFb antikoerper, PTefb antikoerper, cyclin dependent kinase 9 antikoerper, cyclin-dependent kinase 9 (CDC2-related kinase) antikoerper, cyclin-dependent kinase 9 L homeolog antikoerper, cyclin-dependent kinase 9 antikoerper, Cyclin-dependent kinase 9 antikoerper, cyclin-dependent kinase 9 S homeolog antikoerper, CDK9 antikoerper, cdk9 antikoerper, cdk9.L antikoerper, Cdk9 antikoerper, cdk9.S antikoerper
    Hintergrund

    Synonyms: TAK, C-2k, CTK1, CDC2L4, PITALRE, Cyclin-dependent kinase 9, Cell division cycle 2-like protein kinase 4, Cell division protein kinase 9, Serine/threonine-protein kinase PITALRE, Tat-associated kinase complex catalytic subunit, CDK9

    Background: Protein kinase involved in the regulation of transcription. Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP. This complex is inactive when in the 7SK snRNP complex form. Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR, and the negative elongation factors DSIF and NELF. Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis. P-TEFb is also involved in cotranscriptional histone modification, mRNA processing and mRNA export. Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3, integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing. The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro. Replication stress response protein, the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage. In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6. Promotes cardiac myocyte enlargement. RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription. AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth.

    Gen-ID
    1025
    UniProt
    P50750
    Pathways
    Zellzyklus
Sie sind hier:
Kundenservice